| 2022-08-15 |
详情>>
股本变动：
变动后总股本10883.05万股
|
| 2022-08-15 |
详情>>
业绩披露：
2022年中报每股收益-1.4美元,归母净利润-1.52亿美元,同比去年增长-81.9%
|
| 2022-06-02 |
股东大会：
将于2022-06-22召开股东大会
会议内容 ▼▲
- 1.Election of three directors
2.Precatory Declassification Proposal
|
| 2022-05-13 |
详情>>
业绩披露：
2022年一季报每股收益-0.93美元,归母净利润-1.01亿美元,同比去年增长-160.12%
|
| 2022-04-29 |
股东大会：
将于2022-05-26召开股东大会
会议内容 ▼▲
- 1.“FOR ALL” of Tamsin Berry, Marc Elia and Clive A. Meanwell to be elected to serve as Class I members of the Board until the 2025 annual meeting of stockholders (including any and all adjournments, postponements, continuations or reschedulings thereof, or any other meeting of stockholders held in lieu thereof, the “2025 Annual Meeting”) or until their respective successors are duly elected and qualified (the “Nomination Proposal”);
2.“FOR” the adoption of a non-binding, advisory resolution requesting that the Board take all necessary steps to eliminate the classification of the Board in advance of the 2023 Annual Meeting, and thereby require that all directors be elected on an annual basis at the 2023 Annual Meeting and thereafter (the “Declassification Proposal”).
|
| 2022-03-31 |
详情>>
业绩披露：
2021年年报每股收益-5.32美元,归母净利润-2.27亿美元,同比去年增长-247.2%
|
| 2021-12-17 |
复牌提示：
2021-12-16 11:17:50 停牌，复牌日期 2021-12-16 11:22:50
|
| 2021-11-15 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-7.06美元,归母净利润-1.44亿美元,同比去年增长-198.82%
|
| 2021-09-20 |
详情>>
业绩披露：
2021年中报每股收益-0.66美元,归母净利润-8337.3万美元,同比去年增长-84974.49%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-10 |
详情>>
内部人交易：
Adimab, LLC等共交易3笔
|